MXPA00010254A - Tratamiento de disfuncion sexual en ciertos grupos de pacientes. - Google Patents

Tratamiento de disfuncion sexual en ciertos grupos de pacientes.

Info

Publication number
MXPA00010254A
MXPA00010254A MXPA00010254A MXPA00010254A MXPA00010254A MX PA00010254 A MXPA00010254 A MX PA00010254A MX PA00010254 A MXPA00010254 A MX PA00010254A MX PA00010254 A MXPA00010254 A MX PA00010254A MX PA00010254 A MXPA00010254 A MX PA00010254A
Authority
MX
Mexico
Prior art keywords
sexual dysfunction
patient groups
treatment
certain patient
methods
Prior art date
Application number
MXPA00010254A
Other languages
English (en)
Inventor
R Cutler Neal
Original Assignee
R Cutler Neal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/071,457 external-priority patent/US6110489A/en
Priority claimed from US09/166,703 external-priority patent/US6194433B1/en
Priority claimed from US09/175,395 external-priority patent/US6132753A/en
Priority claimed from US09/260,099 external-priority patent/US6132757A/en
Priority claimed from US09/262,715 external-priority patent/US6187790B1/en
Application filed by R Cutler Neal filed Critical R Cutler Neal
Publication of MXPA00010254A publication Critical patent/MXPA00010254A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

Se proporcionan metodos para tratar grupos especificos de pacientes para disfuncion sexual. Los metodos de la presente invencion comprenden la utilizacion de composiciones farmaceuticas en pacientes quienes estan libres de enfermedad cardiaca y/o a quienes no se les ha dado nitratos organicos.
MXPA00010254A 1998-05-01 1999-04-30 Tratamiento de disfuncion sexual en ciertos grupos de pacientes. MXPA00010254A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/071,457 US6110489A (en) 1998-05-01 1998-05-01 Use of quinolines and quinolones to treat male erectile dysfunction
US09/166,703 US6194433B1 (en) 1998-10-05 1998-10-05 Sexual dysfunction in females
US09/175,395 US6132753A (en) 1998-05-01 1998-10-19 Treatment of sexual dysfunction in certain patient groups
US09/260,099 US6132757A (en) 1998-05-01 1999-03-02 Treatment of sexual dysfunction in certain patient groups
US09/262,715 US6187790B1 (en) 1999-03-04 1999-03-04 Use of cilostazol for treatment of sexual dysfunction
PCT/US1999/009610 WO1999056666A1 (en) 1998-05-01 1999-04-30 The treatment of sexual dysfunction in certain patient groups

Publications (1)

Publication Number Publication Date
MXPA00010254A true MXPA00010254A (es) 2002-08-06

Family

ID=27535884

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00010254A MXPA00010254A (es) 1998-05-01 1999-04-30 Tratamiento de disfuncion sexual en ciertos grupos de pacientes.

Country Status (7)

Country Link
EP (1) EP1079764A4 (es)
JP (1) JP2002537231A (es)
AU (1) AU3780699A (es)
BR (1) BR9908716A (es)
CA (1) CA2319542C (es)
MX (1) MXPA00010254A (es)
WO (1) WO1999056666A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6541487B1 (en) 1998-05-01 2003-04-01 R.T. Alamo Ventures I, Llc PDE III inhibitors for treating sexual dysfunction
CA2435876A1 (en) * 2001-01-26 2002-08-01 R.T. Alamo Ventures I, Llc The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
US6767914B2 (en) 2002-03-01 2004-07-27 R.T. Alamo Ventures I, Llc Fluorinated heterocyclic compounds and methods of synthesis
US7041677B2 (en) 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US6730790B2 (en) 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis
US6727262B2 (en) 2002-03-01 2004-04-27 R.T. Alamo Ventures I, Llc Dichlorinated heterocyclic compounds and methods of synthesis
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
AU2345192A (en) * 1992-07-21 1994-02-14 Boots Company Plc, The Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
AU5509099A (en) * 1998-08-03 2000-02-28 Basf Corporation Pyridinones for the treatment of sexual dysfunction

Also Published As

Publication number Publication date
AU3780699A (en) 1999-11-23
JP2002537231A (ja) 2002-11-05
EP1079764A4 (en) 2001-09-12
WO1999056666A1 (en) 1999-11-11
BR9908716A (pt) 2000-11-21
CA2319542C (en) 2005-07-12
EP1079764A1 (en) 2001-03-07
WO1999056666A8 (en) 2000-08-10
CA2319542A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
TW200518752A (en) Combinations of drugs for the treatment of neoplasms
ATE302003T1 (de) Zubereitungen enthaltend apomorphin und sildenafil und ihre verwendung zur behandlung von erektiler dysfunktion
ATE331534T1 (de) Anwendung von zielgerichtetem radium 223 für palliative und therapeutische behandlung von knochenkrebs
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
MY164077A (en) Compositions and uses of et743 for treating cancer
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE69310528T2 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
GB0020504D0 (en) Therapeutic method
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
UA32241A (uk) Спосіб лікування запалювальних процесів у експериментальних тварин
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин
EA200001091A1 (ru) Способ лечения заболеваний, связанных с образованием конкрементов
UA23985A (uk) Спосіб лікуваhhя запальhих захворюваhь вhутрішhіх геhіталій у дівчат та підлітків
UA33571A (uk) Спосіб лікування травматичного перелому нижньої щелепи
UA28928A (uk) Спосіб лікування гнійно-запальних захворювань м'яких тканин
ECSP951424A (es) Procedimiento para la administracion de azitromicina
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees